MedPath

Comparison of Trigger Point Release Technique of Repetitive Needling with Local Anaesthetic agent versus Local Anaesthetic agent plus Steroid in patients with Myofascial Pain Syndrome.

Phase 3
Conditions
Health Condition 1: M791- Myalgia
Registration Number
CTRI/2024/05/066716
Lead Sponsor
I
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients diagnosed with Myofascial trigger points of any duration.

FaileConservative trial of management tried for at least1 week.

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
pain scores measured by the visual analogue scale (VAS) in which 0 indicated no pain and 10 indicated the most intense pain imaginable.Timepoint: Baseline 2 weeks and 6 weeks
Secondary Outcome Measures
NameTimeMethod
Quality of Life Assessment using WHO Bref questieneirTimepoint: WHO Bref questioneir will be assessed before the procedure and 6 weeks after the procedure.
© Copyright 2025. All Rights Reserved by MedPath